Nanosphere Health Sciences Inc (NSHS.CX)
0.025
0.00 (0.00%)
CAD |
CNSX |
Apr 26, 16:00
Nanosphere Health Sciences Cash from Operations (TTM): -0.0378M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -0.0378M |
June 30, 2023 | -0.054M |
March 31, 2023 | -0.1103M |
December 31, 2022 | -0.0879M |
September 30, 2022 | -0.1334M |
June 30, 2022 | -0.1309M |
March 31, 2022 | -0.0776M |
December 31, 2021 | -0.0811M |
September 30, 2021 | -0.0623M |
June 30, 2021 | -0.0081M |
March 31, 2021 | -0.0063M |
December 31, 2020 | -0.0633M |
September 30, 2020 | -0.2075M |
June 30, 2020 | 0.0748M |
March 31, 2020 | -0.6701M |
December 31, 2019 | -1.432M |
September 30, 2019 | -2.100M |
June 30, 2019 | -3.236M |
March 31, 2019 | -3.630M |
December 31, 2018 | -4.198M |
September 30, 2018 | -4.028M |
June 30, 2018 | -3.400M |
March 31, 2018 | -2.645M |
December 31, 2017 | -1.636M |
September 30, 2017 | -1.114M |
Date | Value |
---|---|
June 30, 2017 | -1.060M |
March 31, 2017 | -0.7493M |
December 31, 2016 | -0.3957M |
September 30, 2016 | -0.2685M |
June 30, 2016 | -0.1354M |
March 31, 2016 | -0.1054M |
December 31, 2015 | -0.0685M |
September 30, 2015 | -0.072M |
June 30, 2015 | -0.4498M |
March 31, 2015 | -0.4157M |
December 31, 2014 | -0.4176M |
September 30, 2014 | -0.1338M |
June 30, 2014 | 0.1636M |
March 31, 2014 | -0.3208M |
December 31, 2013 | -0.7536M |
September 30, 2013 | -1.655M |
June 30, 2013 | -2.109M |
March 31, 2013 | -2.320M |
December 31, 2012 | -2.230M |
September 30, 2012 | -2.154M |
June 30, 2012 | -1.664M |
March 31, 2012 | -1.284M |
December 31, 2011 | -1.631M |
September 30, 2011 | -5.859M |
June 30, 2011 | -5.821M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-3.236M
Minimum
Jun 2019
0.0748M
Maximum
Jun 2020
-0.468M
Average
-0.0845M
Median
Cash from Operations (TTM) Benchmarks
Biocure Technology Inc | -0.4423M |
Core One Labs Inc | -- |
Nova Mentis Life Science Corp | -- |
Lobe Sciences Ltd | -2.279M |
Algernon Pharmaceuticals Inc | -4.059M |